Skip to main content

Table 3 Lab, echocardiographic data, and myocardial perfusion index (MPI) on admission

From: Long-term follow-up of therapeutic efficacy of everolimus-eluting bioresorbable vascular scaffold in comparison to everolimus-eluting stent in treatment of chronic total occlusion guided by intracoronary imaging

  EES group BVS group Test p value Sig.
No. = 40 No. = 20
Lab
 Hemoglobin Mean ± SD 13.5 ± 0.68 13.2 ± 0.89 1.448b 0.153 NS
Range 12–14 12–14
 Creatinine Mean ± SD 0.97 ± 0.13 0.99–0.08 − 0.639b 0.525 NS
Range 0.4 – 1.2 0.8–1.2
 ECG NAD 17 (42.5%) 7 (35.0%) 7.265a 0.202 NS
Poor R wave progression 3 (7.5%) 2 (10.0%)
Q wave and inf. 7 (17.5%) 4 (20.0%)
Q wave and ant. 8 (20.0%) 3 (15.0%)
T inversion ant. 5 (12.5%) 1 (5.0%)
LAHB 0 (0.0%) 3 (15.0%)
NAD 17 (42.5%) 7 (35.0%)
Echo
 EF (%) Mean ± SD 57.55 ± 7.55 56.45 ± 11.11 0.453b 0.652 NS
Range 45–73 40–85
 DD (grade) I 1 (2.5%) 0 (0.0%) 0.508a 0.476 NS
II 39 (97.5%) 20 (100.0%)
 Wall motion No 23 (57.5%) 10 (50.0%) 2.161a 0.540 NS
Anterior 13 (32.5%) 7 (35.0%)
Inferior 4 (10.0%) 2 (10.0%)
Lateral 0 (0.0%) 1 (5.0%)
MPI
 Viable 13 (32.5%) 4 (20%) 2.063 0.840 NS
 Ischemia anterior 5 (12.5%) 4 (20%)
 Ischemia inferior 6 (15%) 5 (25%)
 Ischemia lateral 2 (5%) 1 (5%)
 Mixed scar anterior 7 (17.5%) 3 (15%)
 Mixed scar inferior 7 (17.5%) 3 (15%)
  1. aChi-square test
  2. bIndependent t test, NS non-significant, S significant, CBC complete blood count, DD diastolic dysfunction, ECG electrogardiogram